Method Sign up free

Borrower record · Q2 2026

Vaxcare Intermediate II

As filed by HPS Corporate Lending Fund · period end 30 June 2026No sector — one filer, nothing to corroborate

HPS Corporate Lending Fund is the only BDC lending to Vaxcare Intermediate II: $61.5m across two positions at Q2 2026, marked at 101.0 cents. The filed maturities run to June 2032.

Filed fair value
$61.5m
2 funded positions
Aggregate mark
101.0c
cost filed on all 2 positions
Maturities to
2032
one date, 17 June 2032
Periods on record
5
first filed Q2 2025

How this total is counted

Pricing as filed

2 floating tranches · Prime / SOFR
SpreadTranches
325bp1
425bp1

Bar length is the number of tranches filed at that spread. The accented rows hold the middle tranches.

Rate structure

Floating, on all 2 positions whose interest type a filer disclosed.

Maturity profile

all 2 funded positions dated
2032
$61.5m

6.0 years to maturity, weighted by fair value across the 2 dated positions.

Credit flags

The filer reports no position on non-accrual, and no filed tranche pays in kind.

Not in the filings

Sign up for free

Tell me when this changes.

One lender reports Vaxcare Intermediate II today. We will email you when a second one does, when HPS Corporate Lending Fund's mark moves, or when the position leaves the schedule.

Every filing behind this page

1 filer · Q2 2026
FilerCIKFormPeriodFiledAccession
HPS Corporate Lending Fund (HLEND)000183812610-Q2026-06-302026-08-130001628280-26-056772

Related borrowers

Same lender